Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Migraine prevention drug atogepant under Real-World review in korea

NCT ID NCT06603558

Prevention Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study looks at the safety and effectiveness of atogepant, a drug already approved for migraine prevention, in Korean adults. About 3000 people with chronic or episodic migraines will take the drug as prescribed by their doctor and be followed for up to 12 weeks. The goal is to see how well it works and what side effects occur in everyday medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult participants who have been prescribed atogepant for preventive treatment migraine according to the latest approved local label in routine clinical practice.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants with migraine suitable for the treatment with atogepant according to the latest approved local label. * Participants prescribed atogepant in accordance with the approved local label. Exclusion Criteria: * Participants with any contraindication to atogepant as listed on the latest approved local label. * Participants currently participating in another clinical research except observational study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic migraine Episodic migraine Migraine

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    36 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ajou University Hospital - Suwon-si /ID# 284574

    RECRUITING

    Suwon, Gyeonggido, 16499, South Korea

  • Changwon Fatima Hospital /ID# 284572

    RECRUITING

    Changwon-si, Gyeongsangnam-do, 51394, South Korea

  • Chonnam National University Hospital /ID# 275318

    RECRUITING

    Gwangju, Gwangju Gwang Yeogsi, 61469, South Korea

  • Chuncheon Sacred Heart Hospital /ID# 275315

    RECRUITING

    Gangwon-do, Gang Weondo, 24253, South Korea

  • Chungnam National University Hospital /ID# 284724

    RECRUITING

    Daejeon, Daejeon Gwang Yeogsi, 35015, South Korea

  • Daegu Catholic University Medical Center /ID# 284728

    RECRUITING

    Daegu, Gyeongsangbuk-do, 42472, South Korea

  • Dong-A University Medical Center /ID# 275321

    RECRUITING

    Busan, Busan Gwang Yeogsi, 49201, South Korea

  • Ewha Womans University Medical Centre /ID# 275317

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 07985, South Korea

  • Gachon University Gil Medical Center /ID# 284571

    RECRUITING

    Incheon, Gyeonggido, 21565, South Korea

  • Hallym University Dongtan Sacred Heart Hospital /ID# 273581

    RECRUITING

    Hwaseong, Gyeonggido, 18450, South Korea

  • Hallym University Dongtan Sacred Heart Hospital /ID# 280737

    RECRUITING

    Hwaseong, Gyeonggido, 18450, South Korea

  • Hallym University Kangdong Sacred Heart Hospital /ID# 284573

    RECRUITING

    Seoul, 05355, South Korea

  • Hwahong Hospital /ID# 284803

    RECRUITING

    Suwon, Gyeonggido, 16630, South Korea

  • Inha University Hospital /ID# 275320

    RECRUITING

    Incheon, Incheon Gwang Yeogsi, 21565, South Korea

  • Inje University - Ilsan Paik Hospital /ID# 280738

    RECRUITING

    Goyang, Gyeonggido, 10380, South Korea

  • Jeonbuk National University Hospital /ID# 273583

    RECRUITING

    Jeonju, Jeonrabugdo, 54907, South Korea

  • Kangbuk Samsung Hospital /ID# 271893

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03181, South Korea

  • Keimyung University Dongsan Hospital /ID# 284727

    RECRUITING

    Daegu, Gyeongsangbuk-do, 42601, South Korea

  • Korea University Anam Hospital /ID# 284726

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 02841, South Korea

  • Korea University Ansan Hospital /ID# 284725

    RECRUITING

    Ansan-si, Gyeonggido, 15355, South Korea

  • Korea University Guro Hospital /ID# 284569

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 08308, South Korea

  • Life Neurology Clinic /ID# 284729

    RECRUITING

    Hwaseong-si, Gyeonggido, 18478, South Korea

  • National Health Insurance Corporation Ilsan Hospital /ID# 285128

    RECRUITING

    Goyang-si, Gyeonggido, 10444, South Korea

  • Nowon Eulji Medical Center, Eulji University /ID# 275316

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 01830, South Korea

  • On Hospital /ID# 285157

    RECRUITING

    Busan, Busan Gwang Yeogsi, 47261, South Korea

  • Ryu Sang Hyo Neurosurgery Clinic /ID# 284804

    RECRUITING

    Busan, Busan Gwang Yeogsi, 48496, South Korea

  • Samsung Medical Center /ID# 272640

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 06351, South Korea

  • Seoul National University Bundang Hospital /ID# 284508

    RECRUITING

    Seongnam-si, Gyeonggido, 13620, South Korea

  • Seoul National University Hospital /ID# 271892

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Seoul National University Hospital /ID# 272638

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Teunteun Hospital /ID# 284730

    RECRUITING

    Hwaseong-si, Gyeonggido, 18379, South Korea

  • The Catholic University of Korea, Incheon St. Mary's Hospital /ID# 284568

    RECRUITING

    Incheon, Incheon Gwang Yeogsi, 21431, South Korea

  • Uijeongbu Eulji Medical Center - Eulji University /ID# 284855

    RECRUITING

    Uijeongbu-si, Gyeonggido, 11759, South Korea

  • Wonkwang University Hospital /ID# 284567

    RECRUITING

    Iksan, Jeonrabugdo, 54538, South Korea

  • Yongin Severance Hospital /ID# 284570

    RECRUITING

    Yongin-si, Gyeonggido, 16995, South Korea

  • Yonsei University Health System Severance Hospital /ID# 272639

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.